What Is the Best Shampoo for Dandruff?

---

1. What Dandruff Is, and What an Effective Shampoo Must Do

1.1 Dandruff basics

Dandruff is a common, chronic, recurring scalp condition characterized primarily by visible flakes and itching.

Seborrheic dermatitis is a related inflammatory condition that can include more evident redness, irritation, and greasy or adherent scaling. Scientific literature often discusses dandruff and scalp seborrheic dermatitis as related conditions that differ in severity, although the terms should not be treated as interchangeable in every medical, research, or regulatory context.

One of the central biological contributors is Malassezia, a commensal fungus that normally live on human skin (Shuster, 1984; Bergbrant, 1995; Hay, 2011).

The presence of Malassezia does not automatically mean that someone has dandruff (DeAngelis et al., 2005; Turner et al., 2012; Schwartz et al., 2013). The current scientific model focuses on the interaction among:

• Malassezia
• Scalp oils and lipid metabolism
• Individual susceptibility
• Inflammatory status
• Oxidative stress
• Abnormal skin-cell proliferation and differentiation
• Scalp-barrier integrity

A major scientific review (Schwartz et al., 2013) describes four connected phases in the dandruff and seborrheic dermatitis process:

• The Malassezia ecosystem and its interaction with the epidermis
• Initiation and propagation of inflammation
• Disruption of epidermal proliferation and differentiation
• Physical and functional disruption of the skin barrier

Visible flakes are therefore not the entire condition. They are one outward sign of a broader process occurring on and within the scalp’s outer layers.

1.2 Dandruff is more than loose flakes

The outermost part of the scalp is called the stratum corneum. It is composed of flattened cells called corneocytes and organized lipids that help form the skin barrier (Warner et al., 2001).

• Microscopy research has found that dandruff-affected scalp may show:
• Malassezia within the stratum corneum
• Partially nucleated, or parakeratotic, cells
• Abnormal lipid droplets within corneocytes
• Fewer desmosomes connecting neighboring cells
• Excessive, disorganized intercellular lipids
• Irregular corneocyte membranes
• Separation between corneocytes

Some of these abnormalities have been observed even in areas of dandruff-affected scalp where little or no visible flaking was present (Warner et al., 2001; Harding et al., 2002).

This helps explain why simply removing loose flakes is not the same as controlling dandruff.

An effective anti-dandruff shampoo must help address the processes that contribute to recurring flaking while also cleansing away visible scale.

1.3 What does “best dandruff shampoo” mean?

• The word best can refer to different outcomes:
• Maximum reduction in visible flaking
• Faster relief from itching
• Control of more stubborn dandruff
• Lower recurrence after treatment
• Better suitability for continued use
• Better scalp comfort
• Better conditioning and hair feel
• Lower irritation for a particular user

No single study has established one shampoo as superior on every one of these measures for every type of dandruff.

For this article, best shampoo for dandruff means:

The strongest evidence-supported OTC first choice for maximizing dandruff control, while remaining practical enough to use according to its labeled directions.

On that definition, a well-formulated 1% selenium sulfide shampoo receives the edge.

2. Why Comparing Active Ingredients Alone Can Be Misleading

• Dandruff shampoos are commonly ranked by active ingredient:
• Ketoconazole
• Selenium sulfide
• Zinc pyrithione
• Piroctone olamine
• Salicylic acid
• Coal tar

That hierarchy appears simple, but it can conceal important differences in the evidence. Anti-dandruff performance depends on active concentration, delivery and bioavailability of the active, vehicle composition, and consumer compliance/usage (Borda et al., 2019; Schwartz et al., 2011; Schwartz et al., 2014; Mangion et al., 2021).

2.1 Concentration matters

A study of one concentration does not prove that every concentration of the same ingredient will perform identically.

One example is ketoconazole.

A randomized study compared ketoconazole 1% and ketoconazole 2% in 66 people with severe dandruff or seborrheic dermatitis (Piérard-Franchimont et al., 2001).

After two and four weeks, ketoconazole 2% was significantly more effective than ketoconazole 1% in reducing:

• Flaking
• Malassezia colonization on the scalp

The reported difference was statistically significant at p < 0.001. The 2% formulation also showed a trend toward fewer relapses during follow-up.

That result establishes an important principle:

Ketoconazole 1% and ketoconazole 2% should not be treated as equivalent products.

It does not establish that ketoconazole 1% is ineffective. It means the strongest results obtained with ketoconazole 2% cannot automatically be transferred to an OTC bottle containing ketoconazole 1%.

2.2 Additional ingredients matter

Some anti-dandruff shampoos combine an antifungal active with other useful ingredients.

For example, the selenium disulfide shampoo used in the 2024 comparative study also contained salicylic acid (Barbosa et al., 2024). The paper describes salicylic acid as a keratolytic ingredient that helps reduce scalp scale.

The study therefore tested the complete selenium disulfide and salicylic acid formula.

It did not isolate the effect of selenium disulfide alone.

2.3 The finished formulation matters

Consumers use finished shampoos, not isolated active ingredients.

• The full formula can influence:
• How the active remains distributed in the bottle
• How the active reaches the scalp
• How much active is available at the treatment site
• How the shampoo spreads
• How easily it rinses
• Whether it causes irritation
• How the hair feels afterward, both in its wet and dry state
• Whether the user continues using it

The authors of a large selenium sulfide and ketoconazole comparison explicitly cautioned against treating their research as a comparison of isolated molecules.

They emphasized that:

The shampoo vehicle affects bioavailability of the active ingredient.

Cosmetic appeal can affect compliance.

Consumer shampooing habits influence performance.

The study compared specific marketed shampoo systems rather than actives placed in an identical theoretical base.

That is a crucial distinction.

• A statement such as:
• “Ingredient A is stronger than Ingredient B”

may be much broader than the underlying study supports.

The scientifically accurate statement may instead be:

“The finished shampoo containing Ingredient A performed better than the finished shampoo containing Ingredient B under the conditions of this particular study.”

2.4 Frequency of use matters

• The same shampoo may produce different results when used:
• Twice weekly
• Three times weekly
• Every other day
• Every time the user shampoos
• Only when symptoms become noticeable

In the 350-person selenium sulfide study, treatment differences varied by shampooing frequency.

Among participants using the active shampoos two or three times per week, the difference between 1% selenium sulfide and 2% ketoconazole was not statistically significant.

Among participants shampooing more than three times per week, the tested selenium sulfide shampoo produced significantly greater flake reduction.

The current U.S. label for Head & Shoulders Clinical Strength Cooling Itch Relief says to use it at least twice weekly for best results, or as directed by a doctor, and to use it every time the user shampoos for maximum dandruff control.

The current Nizoral A-D label provides a different regimen: adults and children aged 12 and older are directed to use it every three to four days for up to eight weeks, or as directed by a doctor, and then only as needed to control dandruff.

Results from one regimen should not automatically be assumed for another.

2.5 Dandruff severity matters

A study of mild dandruff may not predict results in severe dandruff or scalp seborrheic dermatitis.

Similarly, a product that performs especially well in a severe population may not necessarily be the most practical daily or maintenance shampoo for someone with mild flaking.

• When interpreting a study, ask:
• Who participated?
• How severe was the condition?
• What product was tested?
• What concentration was used?
• How often was it used?
• What outcome was measured?
• How long did the study last?
• Was recurrence measured after treatment stopped?

These details are not academic technicalities. They determine what the study can legitimately tell consumers.

3. What the Evidence Shows About Selenium Sulfide

3.1 What selenium sulfide is

Selenium sulfide, also called selenium disulfide in some scientific literature, is an active ingredient used in shampoos for dandruff and seborrheic dermatitis.

Terminology can vary among publications and markets. Consumers should use the active-ingredient statement on the current product label to identify the relevant formula.

• The current U.S. label for Head & Shoulders Clinical Strength Cooling Itch Relief lists:
• Active ingredient: Selenium Sulfide 1%
• Its stated purpose is:
• Anti-dandruff, anti-seborrheic dermatitis

3.2 The 350-person randomized study (Neumann et al., 1996)

One of the most relevant studies for the OTC dandruff question was a six-week, randomized, double-blind trial involving 350 adults.

• It compared:
• A marketed 1% selenium sulfide shampoo
• A marketed 2% ketoconazole shampoo
• A placebo shampoo

Participants had a minimum baseline dandruff score and were instructed to use their assigned shampoo at least twice per week. Beyond that minimum, they could shampoo as often as they felt was necessary.

A board-certified dermatologist assessed adherent scalp flaking at baseline and after two, four, and six weeks.

• Both active shampoos were significantly more effective than placebo after:
• Two weeks
• Four weeks
• Six weeks

The 1% selenium sulfide shampoo produced significantly more reduction in adherent scalp flaking than the 2% ketoconazole shampoo after:

• Four weeks, p ≤ 0.01
• Six weeks, p ≤ 0.04

At two weeks, the difference between the active shampoos did not reach statistical significance.

• The mean improvement from baseline after six weeks was:

8.4 points with 1% selenium sulfide

6.7 points with 2% ketoconazole

-0.1 points with placebo

The study reported no potential adverse events, and 12 of 350 participants withdrew. Withdrawal rates did not differ significantly among the treatment groups.

3.3 Frequency changed the comparison

The frequency analysis helps explain the result.

After six weeks:

At an average of two uses per week, the difference between the active shampoos was not statistically significant.

At three uses per week, the difference was not statistically significant.

At more than three uses per week, the 1% selenium sulfide shampoo produced significantly greater reduction in adherent scalp flaking than the 2% ketoconazole shampoo.

The study’s conclusion was specific:

The 1% selenium sulfide shampoo tested was more effective at controlling adherent scalp flaking than the 2% ketoconazole shampoo under the simulated consumer-use conditions, with the difference associated with use more than three times per week.

This is unusually relevant to consumers because it evaluated finished products under flexible at-home use conditions rather than forcing every participant into the same limited schedule.

3.4 What this study proves, and what it does not

The study supports this statement:

The specific marketed 1% selenium sulfide shampoo tested performed very strongly against dandruff and produced greater adherent-flake reduction than the tested 2% ketoconazole shampoo at later study visits under the reported consumer-use conditions.

It does not prove:

Every selenium sulfide formula is identical.

Selenium sulfide is always superior to ketoconazole.

Selenium sulfide will work best for every person.

The result can be separated from the complete shampoo formulation.

The same result will occur when products are used at different frequencies.

The study included several Procter & Gamble authors. That commercial connection should be considered alongside the randomized, double-blind design, large sample, placebo group, reported methods, and statistical results.

3.5 The 2024 randomized comparison (Barbosa et al., 2024)

• A 2024 multicenter, double-blind, randomized study compared:
• A shampoo containing 1% selenium disulfide and salicylic acid
• A 2% ketoconazole shampoo

The study included 64 adults with moderate-to-severe scalp seborrheic dermatitis.

Participants used the shampoos according to their respective product directions for 28 days. Researchers evaluated overall severity, total scaling, erythema, irritation, greasiness, itching, quality of life, product satisfaction, and tolerability.

• After 28 days, overall scalp seborrheic dermatitis severity improved by:
• 71% with the selenium disulfide-based shampoo
• 69% with ketoconazole 2%
• The total scale score improved by:
• 75% with the selenium disulfide-based shampoo
• 68% with ketoconazole 2%

Improvements from baseline were statistically significant for both products.

The investigators did not find statistically significant differences between the treatment groups for the measured signs or symptoms at any visit. Both products moved participants from moderate or severe disease at baseline to mild severity after 28 days.

Quality of life improved with both products. The study reported an earlier improvement in the emotions component for the selenium disulfide-based shampoo, and participants gave the selenium formula higher ratings on several measures of hair feel and cosmetic acceptability.

3.6 Important qualifications to the 2024 study

The study does not prove that selenium disulfide alone matched ketoconazole.

The selenium formula also contained salicylic acid, and the authors attributed the observed results to the combination of:

• Selenium disulfide acting on Malassezia overgrowth
• Salicylic acid helping reduce scale
• The study also:
• Included only 64 participants
• Focused on moderate-to-severe scalp seborrheic dermatitis
• Used different labeled application frequencies for the two products
• Was funded by Vichy Laboratories
• Included two authors who were Vichy employees
• Tested a Vichy product, not a Head & Shoulders product
• The accurate conclusion is therefore:

A finished shampoo containing 1% selenium disulfide and salicylic acid produced improvements similar to the tested 2% ketoconazole shampoo over 28 days in this study population.

Taken together with the larger 1996 trial, this is meaningful support for selenium sulfide as a top-tier dandruff technology.

4. What the Evidence Shows About Ketoconazole

4.1 What ketoconazole is

Ketoconazole is an antifungal active used in shampoos for dandruff and seborrheic dermatitis.

Ketoconazole has a strong clinical reputation, particularly because of research involving the 2% concentration.

In the United States, the current Nizoral A-D label identifies ketoconazole 1% as its active ingredient and states that the shampoo controls the flaking, scaling, and itching associated with dandruff.

4.2 OTC ketoconazole 1% works

A double-blind, placebo-controlled trial evaluated ketoconazole 1% shampoo in 176 people with dandruff (Go et al., 1992).

Participants used the shampoo twice weekly.

After two weeks:

74% of participants using ketoconazole had a good or excellent result.

20% of participants using placebo had a good or excellent result.

After four weeks:

80% of participants using ketoconazole had a good or excellent result.

23% of participants using placebo had a good or excellent result.

The shampoo was described as well tolerated. One participant in the ketoconazole group stopped because of greasy hair.

That evidence supports a clear conclusion:

Nizoral’s active concentration, ketoconazole 1%, is an effective dandruff treatment.

The relevant question is not whether ketoconazole 1% works.

It does.

The question is whether the evidence establishes that it is superior to every other OTC dandruff shampoo.

It does not.

4.3 Ketoconazole 2% is stronger than ketoconazole 1% (Piérard-Franchimont et al., 2001)

The direct 1% versus 2% study is critical.

In the 66-person randomized trial, ketoconazole 2% was significantly more effective than ketoconazole 1% at reducing flaking and Malassezia density after both two and four weeks.

This means that evidence generated with ketoconazole 2% should be identified as evidence for the 2% concentration.

It should not be presented without qualification as evidence for OTC Nizoral A-D with ketoconazole 1%.

4.4 Ketoconazole 2% versus zinc pyrithione 1% (Piérard-Franchimont et al., 2002)

A multicenter randomized trial recruited 343 participants, of whom 331 were eligible and randomized.

The participants had severe dandruff or scalp seborrheic dermatitis.

• The study compared:
• Ketoconazole 2%
• Zinc pyrithione 1%
• After four weeks, total dandruff severity improved by:
• 73% with ketoconazole 2%
• 67% with zinc pyrithione 1%

The difference favored ketoconazole and was statistically significant. The recurrence rate during follow-up was also lower in the ketoconazole group.

This is legitimate evidence favoring the tested ketoconazole 2% shampoo over the tested zinc pyrithione 1% shampoo in people with severe dandruff or seborrheic dermatitis.

However, the clinical portion of the study was open-label because the shampoos had different colors and smells. The products were also used according to their respective label instructions rather than an identical schedule.

Most importantly, the study establishes:

Ketoconazole 2% outperformed the tested zinc pyrithione 1% product in this severe population.

It does not establish:

Ketoconazole 1% is superior to selenium sulfide 1%.

Ketoconazole 1% is superior to zinc pyrithione 1%.

Ketoconazole is the best daily-use shampoo.

Nizoral A-D is universally superior to every Head & Shoulders formula.

The same difference applies to mild dandruff.

4.Why ketoconazole still deserves consideration

It may be a reasonable alternative when:

A selenium sulfide shampoo is not effective enough for the individual.

Selenium sulfide is not well tolerated.

The user prefers ketoconazole’s labeled schedule.

A healthcare professional recommends a ketoconazole-containing product.

Its strength should be described accurately, without borrowing unqualified superiority from studies of a different concentration.

5. What the Evidence Shows About Zinc Pyrithione

5.1 What zinc pyrithione is

Zinc pyrithione, commonly abbreviated ZPT, is an anti-dandruff active with antifungal activity.

It has been used in many anti-dandruff shampoos, including traditional Head & Shoulders formulations.

The current ingredient in any specific product should always be confirmed on the package because formulas and market availability can change.

5.2 Zinc pyrithione and visible dandruff

The large ketoconazole comparison showed that zinc pyrithione 1% produced a 67% improvement in total dandruff severity after four weeks in people with severe dandruff or scalp seborrheic dermatitis.

Although ketoconazole 2% produced a greater improvement in that study, a 67% reduction confirms that the tested zinc pyrithione shampoo was an effective treatment, not an inactive or merely cosmetic shampoo.

5.3 Evidence beneath the visible surface

A randomized, double-blind study examined dandruff-affected scalp using transmission electron microscopy (Warner et al., 2001).

The microscopy comparison included 12 people with moderate-to-severe dandruff or seborrheic dermatitis who used either:

• A commercial small-particle zinc pyrithione Head & Shoulders shampoo
• A matching placebo shampoo without zinc pyrithione

Participants shampooed every other day for three weeks.

• The commercial zinc pyrithione shampoo produced significantly greater improvement than placebo in:
• Visual dandruff grading
• The study’s combined microscopic assessment of scalp structural abnormalities
• Following treatment, the researchers reported:
• Fewer Malassezia
• Reduced excessive intercellular lipid
• Elimination of observed parakeratotic nuclei
• Fewer intracellular lipid inclusions
• More normal intercellular lipid organization
• Fewer highly interdigitated, abnormal corneocytes
• This supports an important conclusion:

The tested zinc pyrithione shampoo did more than remove loose surface flakes. Its use was associated with improvement in measured structural abnormalities of dandruff-affected scalp.

The study was small, used a specialized sampling method with acknowledged limitations, and was funded by Procter & Gamble. All authors were Procter & Gamble employees.

The findings are therefore best treated as mechanistic evidence that complements larger clinical studies.

5.4 Zinc pyrithione and biomolecular measures (Mills et al., 2012; Schwartz et al., 2013)

• A broader review evaluated dandruff and seborrheic dermatitis through three levels:
• Visible signs and symptoms
• Scalp structure and function
• Biomolecular changes
• The review describes dandruff-associated changes in biomarkers related to:
• Inflammation
• Epidermal differentiation
• Barrier integrity
• Intercellular lipids

It also summarizes changes after treatment with a commercial 1% potentiated zinc pyrithione shampoo, including significant movement toward normal in several inflammatory, differentiation, and barrier-related measures.

The review was funded by Procter & Gamble. Several authors were employees, and external experts received honoraria for their contributions.

The research nevertheless advances a useful scientific principle:

Dandruff-treatment success can be evaluated not only by counting flakes, but also by measuring the scalp processes associated with producing them.

5.5 Where zinc pyrithione may fit best

The evidence supports zinc pyrithione as a legitimate anti-dandruff treatment with benefits extending beyond visible flake removal (Meldrum et al., 2003; Rogers et al., 2003; Kerr et al., 2011; Schwartz et al., 2015).

• Its most defensible role in the current evidence architecture is:
• Regular dandruff control
• Improved scalp health and stronger scalp skin barrier
• Reduced oxidative stress, itch, and inflammation
• Use within formulas designed to combine treatment with desirable hair conditioning

Zinc pyrithione should not be described as universally inferior simply because ketoconazole 2% produced a modestly larger improvement in one severe-dandruff study.

6. Does Dandruff Return When Treatment Stops?

6.1 The dandruff flare-up study (Locker et al., 2025)

A 2025 randomized, double-blind study examined what happens when people stop using anti-dandruff shampoo.

The study enrolled 100 adults with scalp concerns.

All participants first used Head & Shoulders Classic Clean, described in the study as a commercial zinc pyrithione-based anti-dandruff shampoo, three times per week for two weeks.

Participants were then randomized into two groups:

One group continued using the anti-dandruff shampoo.

One group switched to a commercially available non-anti-dandruff cosmetic shampoo.

• Researchers followed the participants for four additional weeks and measured:
• Malassezia
• Expert-assessed visible flaking
• Scalp impedance
• Skin-barrier biomarkers
• Inflammatory biomarkers
• Oxidative-stress biomarkers
• Self-reported flaking, itching, dryness, and sensitivity

6.2 What happened after anti-dandruff treatment stopped

In the group that changed to the non-anti-dandruff shampoo:

Malassezia increased.

Histamine and complement C3 differed from the continuing-treatment group beginning as early as day three.

Additional inflammatory, oxidative-stress, and barrier-related measures increased later.

Participants eventually reported worse itching and flaking.

Visible flaking returned more slowly than some of the measured biological changes.

No statistically significant increase from baseline was reported for the objective measures in the group that continued using the anti-dandruff shampoo.

The practical interpretation is:

A dandruff-prone scalp may begin changing before obvious flakes return.

This helps explain why continued use of an anti-dandruff shampoo can matter even when the scalp looks clear.

6.3 What the study cannot establish

The study was exploratory.

• The authors reported:
• No formal sample-size calculation for the exploratory biomarker design
• A statistical significance threshold of p < 0.10
• Considerable variation in flaking at baseline
• No defined minimum dandruff score for enrollment
• Possible seasonal influence
• A need to validate the machine-learning component in future research

The study was funded by Procter & Gamble, and most authors were Procter & Gamble employees.

The findings do not establish an exact universal timeline for every dandruff flare. They support the broader conclusion that dandruff-associated scalp changes can precede clearly visible flaking.

6.4 What this means for consumers

Dandruff should generally be viewed as a condition that is controlled, not permanently cured by a single short course of shampoo. For best results, users should follow the labeled directions for the specific product.

Do not assume that all anti-dandruff shampoos should be used at the same frequency or in the same way.

7. Why Shampoo Experience Matters

7.1 Clinical efficacy and real-world effectiveness are different

Clinical efficacy asks whether a product works under the conditions of a study.

• Real-world effectiveness also depends on whether people:
• Use enough product
• Reach the scalp
• Follow the recommended shampoo treatment schedule
• Leave the product on or rinse it according to directions

After rinsing, do not apply a cosmetic shampoo or conditioner without an anti-dandruff ingredient to the scalp

• Continue treatment
• Tolerate the product
• Like how the hair feels afterward

This matters particularly for dandruff because the condition is recurring.

7.2 The conditioning comparison (Draelos et al., 2005)

A double-blind crossover study enrolled 40 women with mild-to-moderate dandruff.

• It compared:
• A conditioning shampoo containing 1% zinc pyrithione
• A 2% ketoconazole shampoo with limited conditioning

Both shampoos improved dandruff.

At the end of the initial crossover comparison, 75% of participants preferred the conditioning zinc pyrithione shampoo. The investigator also reported statistically significant differences favoring the zinc pyrithione shampoo on various measures of:

• Hair smoothness
• Combing ease
• Frizz or flyaway control

The crossover design meant that later dandruff results could not be attributed cleanly to one product, because participants had been exposed to both shampoos.

The study does not prove zinc pyrithione had greater anti-dandruff efficacy than ketoconazole 2%.

It demonstrates something different:

The complete shampoo experience can affect product preference and may influence continued use.

7.3 Why that belongs in the “best” assessment

A shampoo cannot deliver its intended treatment benefit if it is not used consistently enough to do so. Dandruff and seborrheic dermatitis are chronic conditions that require consistent treatment; thus, compliance and the desire to continue using the anti-dandruff shampoo are of utmost importance.

Maximum laboratory antifungal activity is not the only relevant measure.

• For a recurring condition, the best practical choice must balance:
• Anti-dandruff activity
• Scalp tolerability
• Hair feel
• Use frequency
• Consumer adherence

This is one reason finished products should be compared as complete systems rather than ranked only by the name of the active ingredient.

8. Why Dandruff Studies Sometimes Appear to Conflict

Scientific studies of dandruff shampoos do not always point to the same winner.

That does not necessarily mean one study is wrong.

Often, the studies are answering different questions.

8.1 Different concentrations

Ketoconazole 1% is not the same concentration as ketoconazole 2%.

Selenium sulfide 1% is not the same concentration as selenium sulfide 2.5%.

Results should be attributed to the concentration tested.

8.2 Different finished formulations

A shampoo formula affects active delivery, cosmetic properties, and how the consumer uses the product.

Two shampoos containing the same percentage of an active ingredient may not be identical treatment systems.

8.3 Different combination formulas

The 2024 selenium disulfide study included salicylic acid in the test shampoo.

Its result applies to the combined finished formula, not only to selenium disulfide.

8.4 Different use schedules

• The studies reviewed used regimens including:
• Twice weekly
• At least twice weekly
• Three times weekly
• Every other day
• Flexible consumer-directed use

Shampoo frequency greatly influences both perceived and technical endpoints related to the health of the scalp and hair (Neumann et al., 1996; Punyani et al., 2021).

8.5 Different populations

Some trials included people with ordinary dandruff.

Others required severe dandruff or moderate-to-severe scalp seborrheic dermatitis.

The results may not transfer perfectly across those populations.

8.6 Different endpoints

• Studies may measure:
• Visible flaking
• Adherent scalp flaking
• Total disease severity
• Malassezia counts
• Itch
• Redness
• Greasiness
• Recurrence
• Barrier integrity
• Inflammatory biomarkers
• Quality of life
• Hair condition
• Perceived improvement of symptoms
• Overall product satisfaction

A product can perform better on one outcome and similarly on another.

8.7 Different follow-up periods

A four-week treatment result does not necessarily show how quickly dandruff will recur after treatment stops.

Studies that include a follow-up phase may provide additional information about maintenance and relapse.

8.8 Different study designs

• The evidence includes:
• Double-blind studies
• Open-label studies
• Placebo-controlled studies
• Active-comparator studies
• Crossover studies
• Mechanistic microscopy studies
• Biomarker studies
• Narrative or scientific reviews

These designs do not carry identical strengths or answer identical questions.

8.9 Different sponsorship

Some, but not all, of studies in this evidence base were funded by companies that manufacture anti-dandruff products, including Procter & Gamble, Unilever, and Vichy Laboratories.

Industry funding does not automatically invalidate research.

It does make transparency especially important.

• Readers should consider:
• Randomization
• Blinding
• Sample size
• Comparator choice
• Product matching
• Relevance of the endpoint
• Statistical methods
• Disclosures
• Whether other research points in the same direction

The strongest conclusion is one supported by multiple independent lines of evidence rather than a single favorable study.

9. Which Dandruff Shampoo Should You Choose?

9.1 For maximum OTC dandruff control

Start with a well-formulated shampoo containing 1% selenium sulfide.

The most relevant evidence includes:

A 350-person randomized, double-blind trial in which the tested 1% selenium sulfide shampoo reduced adherent scalp flaking more than the tested 2% ketoconazole shampoo after four and six weeks under the reported consumer-use conditions.

A 2024 randomized trial in which a finished 1% selenium disulfide and salicylic acid formula produced improvements similar to 2% ketoconazole in moderate-to-severe scalp seborrheic dermatitis.

Direct evidence that ketoconazole 2% performs more strongly than ketoconazole 1% in severe dandruff or seborrheic dermatitis, making it inappropriate to treat the two concentrations as interchangeable.

Head & Shoulders Clinical Strength Cooling Itch Relief is a current U.S. example because its Drug Facts label lists selenium sulfide 1% as the active ingredient.

9.2 For regular control and continued scalp maintenance

A well-formulated zinc pyrithione shampoo is an evidence-supported option.

• Zinc pyrithione evidence includes:
• Substantial reduction in dandruff severity in clinical research
• Improvement in dandruff-associated scalp structure
• Improvement in measured inflammatory, differentiation, and barrier-related markers
• Evidence that conditioning and cosmetic performance can improve product preference

9.3 For an alternative OTC antifungal approach

Nizoral A-D with ketoconazole 1% is an effective alternative.

A placebo-controlled trial found a good or excellent response in 80% of participants using ketoconazole 1% versus 23% using placebo after four weeks.

Nizoral A-D may be a reasonable choice when another active is not effective, is not well tolerated, or does not suit the individual’s treatment preferences.

9.4 Always follow the current label

Do not use one product according to another product’s instructions.

The labeled frequency, precautions, and directions differ among dandruff shampoos.

Current Head & Shoulders Clinical Strength and Nizoral A-D labeling includes product-specific warnings and directions.

9.5 When professional guidance may be appropriate

Seek guidance from a qualified healthcare professional when:

Symptoms are severe or painful.

The scalp is broken, oozing, or markedly inflamed.

Scaling extends beyond the scalp.

There is unexplained or substantial hair loss.

The condition worsens.

Symptoms do not improve with appropriate use of an OTC product.

It is unclear whether the condition is dandruff, seborrheic dermatitis, psoriasis, eczema, or another scalp disorder.

The current labels for both products also specify situations in which use should stop or a doctor should be consulted.

10. Where Head & Shoulders Fits

10.1 Head & Shoulders is a portfolio, not one shampoo

Head & Shoulders should not be evaluated as though every bottle contains the same active ingredient or serves the same treatment need.

• The evidence supports two distinct scientific roles within the portfolio:
• Selenium sulfide for maximum OTC dandruff control
• Zinc pyrithione for regular dandruff control and continued scalp maintenance

The active ingredient on the current label determines which body of evidence is relevant to a particular formula.

10.2 Head & Shoulders Clinical Strength

The current U.S. DailyMed label for Head & Shoulders Clinical Strength Cooling Itch Relief identifies:

• Selenium Sulfide 1%
• Purpose: anti-dandruff and anti-seborrheic dermatitis

Use: helping prevent recurrence of flaking, itching, irritation, scaling, and redness associated with dandruff and seborrheic dermatitis

• The label directs users to:
• Use the shampoo at least twice per week for best results, or as directed by a doctor
• Use it every time they shampoo for maximum dandruff control
• Shake before use
• Wet hair, massage onto the scalp, rinse, and repeat if desired

This makes Head & Shoulders Clinical Strength Cooling Itch Relief a direct example of the 1% selenium sulfide treatment category that receives the strongest recommendation in this review.

10.3 Zinc pyrithione Head & Shoulders shampoos

Head & Shoulders has historically marketed zinc pyrithione anti-dandruff shampoos, and the supplied clinical research studied Head & Shoulders zinc pyrithione formulations.

Because individual formulas can change, consumers should confirm the active ingredient on the current packaging rather than relying on the brand name alone.

10.4 Why the portfolio approach is scientifically useful

Dandruff needs differ.

• Some people prioritize:
• Maximum flake control
• Control of stubborn or persistent dandruff
• Frequent use
• Hair conditioning
• Scalp comfort
• A specific active ingredient
• A specific use schedule

A portfolio containing different active technologies can address more than one of these needs.

That does not mean every Head & Shoulders formula is the best choice for every person.

It means the brand includes evidence-supported technologies across distinct dandruff-use occasions.

11. What Evidence Is Still Missing?

11.1 The ideal OTC comparison

The study that would most clearly answer the consumer question has not been identified in the available evidence.

It would be a large, independent, randomized, double-blind study directly comparing current U.S. formulations containing:

• Selenium sulfide 1%
• Ketoconazole 1%
• Zinc pyrithione 1%
• The study would use the same:
• Dandruff-severity criteria
• Participant population
• Shampooing frequency
• Contact time
• Treatment duration
• Outcome measures
• Follow-up period
• It would also evaluate:
• Visible flaking
• Itch
• Scalp comfort
• Recurrence
• Tolerability
• Hair condition
• Continued-use preference

Without that study, no one can honestly say that one current OTC product has been definitively proven superior to every other option under identical conditions.

11.2 Why the absence of that study does not make all options equal

Scientific uncertainty does not mean there is no useful evidence.

The available research still shows that:

Selenium sulfide is a potent, evidence-supported dandruff active.

Specific 1% selenium sulfide shampoo systems have performed strongly against 2% ketoconazole in randomized research.

Ketoconazole 1% is effective against dandruff.

Ketoconazole 2% can outperform ketoconazole 1%.

Zinc pyrithione is effective and has evidence across visible, structural, and biomolecular measures.

Formulation and treatment regimen materially affect study interpretation.

12. Bottom Line

When the evidence is brought together:

Dandruff is more than loose flakes. It is associated with Malassezia, inflammation, oxidative stress, abnormal epidermal differentiation, and barrier disruption.

The active ingredient alone does not determine shampoo performance. Concentration, full formulation, additional ingredients, use frequency, severity, and adherence all matter.

Ketoconazole 1% and ketoconazole 2% are not interchangeable. Ketoconazole 2% was significantly more effective than ketoconazole 1% in a direct study of severe dandruff and seborrheic dermatitis.

OTC ketoconazole 1% works. In a placebo-controlled trial, 80% of participants using ketoconazole 1% had a good or excellent response after four weeks, compared with 23% using placebo.

Specific 1% selenium sulfide shampoo systems have performed extremely well. In a 350-person randomized study, the tested 1% selenium sulfide shampoo produced greater adherent-flake reduction than the tested 2% ketoconazole shampoo after four and six weeks under the study’s consumer-use conditions.

A recent selenium disulfide combination formula also performed similarly to 2% ketoconazole. The tested shampoo contained both 1% selenium disulfide and salicylic acid, so the result applies to the finished system.

Zinc pyrithione has a substantial evidence base. Its benefits include visible dandruff reduction and improvement in measured structural and biomolecular abnormalities associated with dandruff-affected scalp.

Continued use matters. Measurable changes associated with a dandruff flare may begin before visible flakes return.

---

References

1. Barbosa, V., Melo, D. F., Vañó-Galván, S., Lutchmanen-Kolanthan, V., Sant’Anna, B., Leclerc-Mercier, S., & Reygagne, P. (2024). A comparative randomized clinical study assessing the efficacy of a 1% selenium disulfide-based shampoo versus 2% ketoconazole shampoo in subjects with moderate to severe scalp seborrheic dermatitis. Skin Appendage Disorders, 10, 497–504. .
2. Bergbrant, I. (1995). Seborrhoeic dermatitis and pityrosporum yeasts. Current Topics in Medical Mycology, 6, 95-112.
3. Borda, L.J., Perper, M, & Keri JE. (2018). Treatment of seborrheic dermatitis: a comprehensive review. Journal of Dermatological Treatment. 30(2):158–169.
4. DeAngelis, Y. M., Gemmer, C. M., Kaczvinsky, J. R., Kenneally, D. C., Schwartz, J. R., & Dawson, T. L. Jr. (2005). Three etiologic facets of dandruff and seborrheic dermatitis: Malassezia fungi, sebaceous lipids, and individual sensitivity. Journal of Investigative Dermatology Symposium Proceedings, 10, 295-297.
5. Draelos, Z. D., Kenneally, D. C., Hodges, L. T., Billhimer, W., Copas, M., & Margraf, C. (2005). A comparison of hair quality and cosmetic acceptance following the use of two anti-dandruff shampoos. Journal of Investigative Dermatology Symposium Proceedings, 10, 201–204. .
6. Go, I. H., Wientjens, D. P. W. M., & Koster, M. (1992). A double-blind trial of 1% ketoconazole shampoo versus placebo in the treatment of dandruff. Mycoses, 35, 103–105.
7. Harding, C. R., Moore, A. E., Rogers, J. S., Meldrum, H., Scott, A. E., & McGlone, F. P. (2002). Dandruff: A condition characterized by decreased levels of intercellular lipids in scalp stratum corneum and impaired barrier function. Archives of Dermatological Research, 294, 221-230.
8. Hay, R. J. (2011). Malassezia, dandruff and seborrhoeic dermatitis: An overview. British Journal of Dermatology, 165(Suppl. 2), 2-8.
9. Kerr, K., et al., A description of epidermal changes associated with symptomatic resolution of dandruff: Biomarkers of scalp health. Intl J Derm, 2011. 50: p. 102-113.
10. Locker, K. C. S., Bacon, R. A., Caterino, T. L., et al. (2025). Understanding the dandruff flare-up: A cascade of measurable and perceptible changes to scalp health. International Journal of Cosmetic Science. .
11. Mangion, S. E., Holmes, A. M., & Roberts, M. S. (2021). Targeted delivery of zinc pyrithione to skin epithelia. International Journal of Molecular Sciences, 22, 9730.
12. Mills, K. J., Hu, P., Henry, J., et al. (2012). Dandruff/seborrhoeic dermatitis is characterized by an inflammatory genomic signature and possible immune dysfunction: Transcriptional analysis of the condition and treatment effects of zinc pyrithione. British Journal of Dermatology, 166(Suppl. 2), 33-40.
13. Meldrum, H., et al., The characteristic decrease of scalp stratum corneum lipids in dandruff is reversed by the use of a zinc pyrithione (ZnPTO) containing shampoo. IFSCC Magazine, 2003. 6: p. 3-6.
14. Neumann, P. B., Coffindaffer, T. W., Cothran, P. E., Jones, J. F., McCoy, J. A., Rains, G. Y., & Reed, B. R. (1996). Clinical investigation comparing 1% selenium sulfide and 2% ketoconazole shampoos for dandruff control. Cosmetic Dermatology, 9(12).
15. Ozturk, P., Arican, O., Belge Kurutas, E., & Karakas, T. (2013). Oxidative stress in patients with scalp seborrheic dermatitis. Acta Dermatovenerologica Croatica, 21, 80-85.
16. Piérard-Franchimont, C., Piérard, G. E., Arrese, J. E., & De Doncker, P. (2001). Effect of ketoconazole 1% and 2% shampoos on severe dandruff and seborrhoeic dermatitis: Clinical, squamometric and mycological assessments. Dermatology, 202, 171–176. .
17. Piérard-Franchimont, C., Goffin, V., Decroix, J., & Piérard, G. E. (2002). A multicenter randomized trial of ketoconazole 2% and zinc pyrithione 1% shampoos in severe dandruff and seborrheic dermatitis. Skin Pharmacology and Applied Skin Physiology, 15, 434–441. .
18. Pople, J. E., Bhogal, R. K., Moore, A. E., Jenkins, G., & Harding, C. R. (2019). Changes in epidermal morphology associated with dandruff. International Journal of Cosmetic Science, 41, 357-363.
19. Punyani, S., Tosti, A., Hordinsky, M., et al. (2021). The impact of shampoo wash frequency on scalp and hair conditions. Skin Appendage Disorders, 7, 183-193.
20. Rogers, J., et al., Increased scalp skin lipids in response to antidandruff treatment containing zinc pyrithione. Arch Dermatol Res, 2003. 295: p. 127-129
21. Schwartz, J. R., Bacon, R. A., Shah, R., Mizoguchi, H., & Tosti, A. (2011). New insights on dandruff/seborrhoeic dermatitis: The role of the scalp follicular infundibulum in effective treatment strategies. British Journal of Dermatology, 165(Suppl. 2), 18-23.
22. Schwartz, J. R., Johnson, E. S., & Dawson, T. L. Jr. (2014). Zinc pyrithione: Critical pharmacological factors in achieving efficacious dandruff treatment products. In A. O. Barel, M. Paye, & H. I. Maibach (Eds.), Handbook of Cosmetic Science and Technology (4th ed., pp. 627-633). CRC Press.
23. Schwartz, J. R., Messenger, A. G., Tosti, A., et al. (2013). A comprehensive pathophysiology of dandruff and seborrheic dermatitis: Towards a more precise definition of scalp health. Acta Dermato-Venereologica, 93, 131–137. .
24. Schwartz, J., et al., The role of oxidative damage in poor scalp health: ramifications to causality and associated hair growth. Intl J Cosm Sci, 2015. 37 (Suppl 2): p. 9-15.
25. Shuster, S. (1984). The aetiology of dandruff and the mode of action of therapeutic agents. British Journal of Dermatology, 111, 235-242.
26. Turner, G. A., Hoptroff, M., & Harding, C. R. (2012). Stratum corneum dysfunction in dandruff. International Journal of Cosmetic Science, 34, 298-306.
27. Turner, G. A., Matheson, J. R., Li, G. Z., Fei, X. Q., Zhu, D., & Baines, F. L. (2013). Enhanced efficacy and sensory properties of an anti-dandruff shampoo containing zinc pyrithione and climbazole. International Journal of Cosmetic Science, 35, 78-83.
28. Warner, R. R., Schwartz, J. R., Boissy, Y., & Dawson, T. L. Jr. (2001). Dandruff has an altered stratum corneum ultrastructure that is improved with zinc pyrithione shampoo. Journal of the American Academy of Dermatology, 45, 897–903. .
29. U.S. National Library of Medicine. Head & Shoulders Clinical Strength Cooling Itch Relief, selenium sulfide shampoo, Drug Facts label. Label updated October 3, 2025.
30. U.S. Food and Drug Administration. Nizoral Anti-Dandruff, ketoconazole 1%, Drug Facts label. 2025 labeling.